Our news

Read through our press releases to follow Signifierʼs latest
news and updates

Snoozeal Device and SmartPhone

New Published Study Explores Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea

CMS Sets Pricing with New HCPCS Codes for eXciteOSA Therapy, Expanding Access to Innovative Daytime Sleep Apnea Treatment

Signifier Medical Technologies Announces Upcoming Publication of Randomized Controlled Trial Results Examining High-Intensity (Active) Vs. Low-Intensity (Sham) Neuromuscular Electrical Stimulation in Patients for 6 Weeks

Neuromuscular Electrical Stimulation as a treatment for obstructive sleep apnea gains traction with a recently announced World Sleep 2023 Congress symposium

Appointment of new Board

Signifier Medical Technologies Announces Partnership with Sunrise, the company revolutionizing home sleep testing for sleep apnea diagnosis

Signifier Medical Technologies Wins Edison Award for Innovative Sleep Apnea Treatment

Nasdaq congratulates Signifier Medical Technologies for treating 10,000 patients with eXciteOSA, a daytime therapy for sleep apnea

Signifier Medical Technologies Reaches a Wider Patient Population with FDA Approval to Remove Dental Contraindications for eXciteOSA

Signifier Medical Technologies Announces Participation In Piper Sandler Healthcare Conference

Signifier Medical Technologies’ eXciteOSA®, the only FDA-authorized daytime therapy for primary snoring and mild obstructive sleep apnea, demonstrates real-world adherence to treatment of over 80%

Signifier Medical Technologies Announces Publication of Peer-Reviewed Analysis Demonstrating Improvement in Obstructive Sleep Apnea Severity with Neuromuscular Electrical Stimulation

Signifier Medical Technologies Announces $49MM Purchase of Existing Shares by Waha Capital, Angelus Sano Ventures and Segulah Medical Acceleration

Signifier Medical Technologies is granted HCPCS Codes for eXciteOSA to help patients access innovative technology

eXciteOSA® Daytime Sleep Apnea Therapy Device Surpasses 50,000 Patient Session Milestone

Signifier Medical Technologies Raises $35M in Series D Funding Round

Signifier® Medical Receives Prestigious 2020 GOOD DESIGN Award for Superior Design Excellence

Signifier® Medical Ushers In New Era of Treatment for Sleep Apnea and Snoring with FDA Approval of eXciteOSA® Device

Signifier® Medical Technologies Announces Award of UK NHS Supply Chain Tender

Signifier® Medical Technologies appoints Alastair Maxwell as Chief Financial Officer

Signifier® Medical Technologies appoints Jim Hinrichs, former CFO and Director of CareFusion and Alere, to its Board

Signifier® Medical Technologies appoints Travis Nieman as Managing Director International

Signifier® Medical Technologies Wins IDEA Design Award 2020 for eXciteOSA®, the World’s First, Daytime Treatment Device That Tackles the Root Cause of Sleep-Disordered Breathing

Signifier® Medical Technologies Closes $10M Series C Funding Round

Global Webinar on: “Precision Medicine and Non-Invasive Therapies for Mild Obstructive Sleep Apnea”

Signifier® Medical Technologies appoints Philip Hess, former President & CEO of Bose Corporation, as Chief Operating Officer

Webinar on Precision Medicine and Non-Invasive Therapies for Mild Obstructive Sleep Apnea

Signifier® Medical Technologies Appoints New Senior Member to the USA Organization

Signifier® Medical Technologies Hosted a Global Webinar on: “Latest Advances in the Management of Sleep Disordered Breathing”

Signifier® Medical Technologies Wins iF Design Award 2020 for Design Excellence for eXciteOSA®, the World’s First, Daytime Treatment Device That Tackles the Root Cause of Sleep Apnoea and Snoring

Signifier® Medical Technologies appoints David Ritscher as Chief Engineer

Signifier® Medical Technologies Announces Participation In JP Morgan 2020 Global Healthcare Conference

Signifier® Medical Technologies Announces Participation In Jefferies 16th European Medtech Conference

Signifier® Medical Technologies Announces Participation In Morgan Stanley 2019 Global Medtech Conference

Signifier® Medical Technologies Announces Participation In Goldman Sachs 2019 European Medtech Conference

Signifier® Medical Technologies Closes an Oversubscribed Series B Funding Round; Driving Innovation in the Sleep Market

Signifier® Medical Technology Appoints Med-Tech Veteran Kieran T. Gallahue as Chairman and Non-Executive Director